HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.395
-0.005 (-1.28%)
Apr 29, 2026, 11:48 AM EDT - Market open
HCW Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | -7.96 | -30.02 | -24.99 | -14.9 | -12.86 | Upgrade
|
| Depreciation & Amortization | 1.04 | 1.18 | 1.14 | 0.72 | 0.54 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.5 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.27 | - | -0.26 | 0.19 | 0.07 | Upgrade
|
| Stock-Based Compensation | 0.77 | 1.01 | 1 | 1.12 | 0.36 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 5.25 | - | - | Upgrade
|
| Other Operating Activities | -6.23 | -0 | -0 | 0 | -0.54 | Upgrade
|
| Change in Accounts Receivable | 0.55 | 0.95 | -1.12 | -0.28 | 2.37 | Upgrade
|
| Change in Accounts Payable | -3.47 | 11.87 | 1.62 | 0.42 | 1.89 | Upgrade
|
| Change in Other Net Operating Assets | 0.14 | 0.78 | -5.14 | 2.35 | -2.8 | Upgrade
|
| Operating Cash Flow | -13.39 | -14.23 | -22.51 | -10.39 | -10.98 | Upgrade
|
| Capital Expenditures | - | -0.26 | -6.2 | -10.28 | -0.05 | Upgrade
|
| Investment in Securities | - | - | 10 | 24.98 | -34.97 | Upgrade
|
| Investing Cash Flow | - | -0.26 | 3.8 | 14.71 | -35.02 | Upgrade
|
| Long-Term Debt Issued | 0.15 | 6.91 | - | 6.45 | - | Upgrade
|
| Total Debt Issued | 0.15 | 6.91 | - | 6.45 | - | Upgrade
|
| Long-Term Debt Repaid | -0.13 | -0.12 | -0.04 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.02 | 6.79 | -0.04 | 6.45 | - | Upgrade
|
| Issuance of Common Stock | 8.03 | 6.46 | 0.02 | 0.02 | 56.03 | Upgrade
|
| Other Financing Activities | 2.61 | 2.32 | - | -0.19 | -6.76 | Upgrade
|
| Financing Cash Flow | 10.67 | 15.57 | -0.01 | 6.27 | 49.27 | Upgrade
|
| Net Cash Flow | -2.72 | 1.08 | -18.73 | 10.6 | 3.27 | Upgrade
|
| Free Cash Flow | -13.39 | -14.49 | -28.72 | -20.66 | -11.02 | Upgrade
|
| Free Cash Flow Margin | -24693.20% | -564.48% | -1010.51% | -307.36% | - | Upgrade
|
| Free Cash Flow Per Share | -6.38 | -14.94 | -31.97 | -23.07 | -23.49 | Upgrade
|
| Cash Interest Paid | 0.6 | 0.57 | 0.28 | 0.13 | - | Upgrade
|
| Levered Free Cash Flow | -15.63 | 0.42 | -15.29 | -15.73 | -5.68 | Upgrade
|
| Unlevered Free Cash Flow | -15.1 | 0.83 | -15.12 | -15.65 | -5.68 | Upgrade
|
| Change in Working Capital | -2.78 | 13.6 | -4.64 | 2.49 | 1.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.